| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |